Asahi Kasei has entered into a joint venture deal with China National Bluestar (Group) Co Ltd to produce and sell modified polyphenylene ether (mPPE) in China, the Japanese producer said on Tuesday.
The companies aim to produce 30,000 tonnes/year of polymer PPE (polyphenylene ether) and 20,000 tonnes/year mPPE.
Financial details of the deal were not disclosed.
“Asahi Kasei and Bluestar will now begin studying the construction of manufacturing facilities for 2,6-xylenol, PPE, and mPPE, and proceed with detailed evaluation of the economics of the joint business targeting a final investment decision by March 2018,” Asahi Kasei said.
Production will use Bluestar’s technology for 2,6-xylenol and PPE, together with Asahi Kasei’s mPPE compounding technology and applications development capability “to facilitate further expansion in the growing Chinese market”, Asahi Kasei said.
Asahi Kasei and Bluestar created two joint venture firms to separately handle the manufacturing and sales of mPPE operations in China.
Bluestar is a subsidiary of China National Chemical Corp (ChemChina).
Source: ICIS News
Appointed Borealis CEO in 2021, Thomas has led key initiatives including the sale of the nitrogen business, acquisitions of Rialti Spa and Integra Plastics AD, and Borouge’s IPO. He also made the final investment decision for the Borouge 4 plant, set to be the world’s largest polyolefin complex.
The Chemours Co. today named interim CEO Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately. Dignam has been interim CEO since late February, when former CEO Mark Newman was placed on leave due to an internal investigation.
Neste Corp. (Espoo, Finland) has completed its organizational change process, announced on 1 November 2023. Neste informed that it will merge its three renewable business units into one Renewable Products business unit as well as restructure its functions to better support business-driven ways of working.